
In the realm of Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, four promising pipeline agents are currently under late-stage development across the seven major markets (7MM), including the… Continue Reading New ADHD Treatments Herald Comorbid Anxiety & Depression